EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Irreversible Electroporation in Pancreatic Cancer—An Evolving Experimental and Clinical Method

Agnieszka Gajewska-Naryniecka iD, Urszula Szwedowicz, Zofia Łapińska iD, Julia Rudno-Rudzińska, Wojciech Kielan, Julita Kulbacka iD

International Journal of Molecular Sciences · 23.02.2023 · 24 (5) · 4381

DOI: 10.3390/ijms24054381 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.02.2023. Verfasst von Agnieszka Gajewska-Naryniecka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer has no symptoms until the disease has advanced and is aggressive cancer with early metastasis. Up to now, the only curative treatment is surgical resection, which is possible in the early stages of the disease. Irreversible electroporation treatment offers new hope for patients with unresectable tumors. Irreversible electroporation (IRE) is a type of ablation therapy that has been explored as a potential treatment for pancreatic cancer. Ablation therapies involve the use of energy to destroy or damage cancer cells. IRE involves using high-voltage, low-energy electrical pulses to create resealing in the cell membrane, causing the cell to die. This review summarizes experiential and clinical findings in terms of the IRE applications. As was described, IRE can be a non-pharmacological approach (electroporation) or combined with anticancer drugs or standard treatment methods. The efficacy of irreversible electroporation (IRE) in eliminating pancreatic cancer cells has been demonstrated through both in vitro and in vivo studies, and it has been shown to induce an immune response. Nevertheless, further investigation is required to assess its effectiveness in human subjects and to comprehensively understand IRE’s potential as a treatment option for pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAntineoplastic AgentsHumansCombined Modality TherapyElectroporationTreatment Outcome

Stichwörter der Autor:innen

immune responseirreversible electroporationpancreatic cancer

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Molecular and Cellular Biology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.
  • 2nd Department of General Surgery and Surgical Oncology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.
  • Department of Immunology, State Research Institute Centre for Innovative Medicine, Santariškių 5, 08410 Vilnius, Lithuania.

ORCID-Profile: Agnieszka Gajewska-Naryniecka, Zofia Łapińska, Julita Kulbacka

Förderung

  • Medical Research Agency

Zitieren

APA

Gajewska-Naryniecka, A., Szwedowicz, U., Łapińska, Z., Rudno-Rudzińska, J., Kielan, W., & Kulbacka, J. (2023). Irreversible Electroporation in Pancreatic Cancer—An Evolving Experimental and Clinical Method. International Journal of Molecular Sciences, 24(5), 4381. https://doi.org/10.3390/ijms24054381

Vancouver

Gajewska-Naryniecka A, Szwedowicz U, Łapińska Z, Rudno-Rudzińska J, Kielan W, Kulbacka J. Irreversible Electroporation in Pancreatic Cancer—An Evolving Experimental and Clinical Method. International Journal of Molecular Sciences. 2023;24(5):4381. doi:10.3390/ijms24054381

BibTeX
@article{GajewskaNaryniecka2023,
  author = {Gajewska-Naryniecka, Agnieszka and Szwedowicz, Urszula and Łapińska, Zofia and Rudno-Rudzińska, Julia and Kielan, Wojciech and Kulbacka, Julita},
  title = {Irreversible Electroporation in Pancreatic Cancer—An Evolving Experimental and Clinical Method},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {5},
  pages = {4381},
  doi = {10.3390/ijms24054381}
}
Kostenlos starten →